Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedOn 2026-02-23, Contacts/Locations and Study Status were added to the record history, and a deletion occurred on 2026-01-29.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and a funding/operating status notice (and the older v3.4.1 entry) were removed. These are administrative updates to the revision history and do not affect study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check22 days agoChange DetectedA new version (v3.4.1, posted 2026-01-29) adds updates to Study Status and Contacts/Locations plus a government funding notice. The prior version (v3.4.0, 2025-12-24) was deleted.SummaryDifference1%

- Check29 days agoChange DetectedAdded a 'Show glossary' option and introduced green/red color-coded highlights to distinguish additions and deletions. The page updated to display the revision label as v3.4.0 and to include a 'No FEAR Act Data' entry, replacing the previous v3.3.4 entry.SummaryDifference0.8%

- Check43 days agoChange DetectedThe history now shows a new revision entry v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedNew history entries dated 2025-12-24 and 2025-12-23 add Study Status and Contacts/Locations. An earlier entry dated 2025-06-13 was removed.SummaryDifference0.4%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.